Profile data is unavailable for this security.
About the company
Clal Biotechnology Industries Ltd (CBI) is an Israel-based biotechnology investment company. CBI's investments are targeted at bio-pharmaceutical companies, which are at different stages of research and development. The Company is a 59%-owned subsidiary of Clal Industries and Investments Ltd. (CII) that is part of IDB group. Clal Biotechnology Industries Ltd. has a number of portfolio companies, namely Andromeda Biotech Ltd., engaged in the field of type 1 diabetes; D-Pharm Ltd and Trombutech, engaged in the field of ischemic stroke; Mediwound Ltd., engaged in burn and wound management; Biokine Ltd, Biocancell Ltd and CureTech, engaged in the field of cancer; Braintact, engaged in the CNS field and Polyheal Ltd, engaged in wound management, among others.
- Revenue in ILS (TTM)39.14m
- Net income in ILS-31.05m
- Incorporated1993
- Employees3.00
- LocationClal Biotechnology Industries LtdAzrieli CenterTriangle Building 45th flr.TEL AVIV-YAFO 67023IsraelISR
- Phone+972 36121616
- Fax+972 36124545
- Websitehttps://www.cbi.co.il/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unicorn Technologies LP | 0.00 | -13.87m | 12.36m | -- | -- | 0.2626 | -- | -- | -0.3963 | -0.3963 | 0.00 | 1.34 | 0.00 | -- | -- | -- | -25.20 | -- | -25.73 | -- | -- | -- | -- | -- | -- | -0.3438 | 0.00 | -- | -- | -- | -106.29 | -- | -- | -- |
| Merchavia Holdings and Investments Ltd | 460.00k | -16.23m | 12.82m | 1.23k | -- | 0.4435 | -- | 27.86 | -3.87 | -3.87 | 0.0409 | 1.72 | 0.0121 | -- | 1.53 | 374.59 | -42.78 | -3.37 | -43.98 | -3.46 | -- | -- | -3,528.48 | -185.15 | -- | -0.1346 | 0.00 | -- | 90.08 | -10.25 | -349.99 | -- | 37.97 | -- |
| Technoplus Ventures Ltd | 773.26k | 131.38k | 20.75m | 3.00 | 150.95 | 1.08 | 157.96 | 26.84 | 0.0586 | 0.0586 | 0.3314 | 8.18 | 0.0363 | -- | 10.30 | -- | 0.6175 | -1.71 | 0.6395 | -1.78 | -- | -- | 16.99 | -23.59 | -- | -- | 0.0537 | -- | 402.44 | -21.95 | 102.56 | -15.24 | -- | -- |
| Teuza A Fairchild Technology Venture Ltd | 0.00 | -7.43m | 42.04m | -- | -- | 0.6601 | -- | -- | -0.0652 | -0.0652 | 0.00 | 0.559 | 0.00 | -- | -- | -- | -10.70 | -6.14 | -11.06 | -6.65 | -- | -- | -- | -- | -- | -1.69 | 0.00 | -- | -- | -- | 69.78 | -- | -- | -- |
| Clal Biotechnology Industries Ltd. | 39.14m | -31.05m | 51.92m | 3.00 | -- | 0.5225 | -- | 1.33 | -0.1934 | -0.1934 | 0.2815 | 0.6335 | 0.2295 | -- | 15.38 | 13,047,000.00 | -16.47 | -13.69 | -19.34 | -23.73 | -- | -- | -71.77 | -121.02 | -- | -0.3437 | 0.0713 | -- | 327.77 | -12.67 | -323.44 | -- | -72.00 | -- |
| Michman Finance Ltd | 85.27m | 39.68m | 236.68m | 24.00 | 6.14 | 1.59 | 5.77 | 2.78 | 24.33 | 24.33 | 52.35 | 93.84 | 0.1148 | -- | 0.1436 | 3,552,917.00 | 5.34 | -- | 11.70 | -- | -- | -- | 46.54 | -- | -- | -- | 0.7853 | -- | 22.28 | -- | 58.65 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Yelin Lapidot Mutual Fund Management Ltd.as of 31 Mar 2024 | 1.33m | 0.85% |
| Meitav Mutual Funds Ltd.as of 31 Mar 2024 | 410.31k | 0.26% |
| Ayalon Mutual Funds Ltd.as of 28 Mar 2024 | 143.68k | 0.09% |
| KSM Mutual Funds Ltd.as of 31 Mar 2024 | 119.32k | 0.08% |
| Migdal Mutual Funds Ltd.as of 31 Mar 2024 | 57.51k | 0.04% |
| Psagot Mutual Funds Ltd.as of 31 Mar 2024 | 14.84k | 0.01% |
| Harel Mutual Funds Ltd.as of 31 Mar 2024 | 4.92k | 0.00% |
